Skip to main content

Closed

NRXS: NeurAxis, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+32.9% / yr

Operating margin-169.9%

ROIC-119.2%

Financially safe

Stretched

Debt / equity0.06×

Interest coverage-159.7×

Current ratio2.89×

NeurAxis, Inc.

NRXSNew York Stock Exchange Arca·USD·Closed

NeurAxis, Inc.

NRXSNew York Stock Exchange Arca·USD·Closed

$7.01

+6.37%

$7.01

+$0.42 (6.37%)

52W Range

67thpctl

Volume

1.30×avg

Mkt Cap

87.47MUSD

P/E

-8.2TTM

Div Yield

–ann

52W Range

67thpctl

Volume

1.30×avg

Market Cap

87.47MUSD

P/E Ratio

-8.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings